Medline Namic Angiographic Control Syringes

Performance

Date

2026-03-27

Country

Canada

Classification

Type I

Category

Drugs & medical

Source

Health Canada

Copied automatically from the Government of Canada. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the Government of Canada has the exact models, batch codes and remedy, and it takes priority.

Other drugs & medical recalls in Canada

1. 2026-03-31
2. CA
   Drugs & medicalType III

   Auro-Canagliflozin: Affected lots are labelled with the incorrect DIN found on the blister card.

   Product safety

   Health CanadaOfficial notice →
3. CA
   Drugs & medicalType III

   LUXA-D: A capsule containing a foreign product was found in the affected batch.

   Product safety

   Health CanadaOfficial notice →
4. 2026-03-30
5. CA
   Drugs & medicalType II

   Moxifloxacin : assay out of trend

   Product quality

   Health CanadaOfficial notice →
6. 2026-03-26
7. CA
   Drugs & medicalType II

   HIZENTRA: The appearance is out of specification in the affected lot.

   Product safety

   Health CanadaOfficial notice →
8. 2026-03-25
9. CA
   Drugs & medical

   Unauthorized and counterfeit health products seized at Thumbs Up 4 Shiatsu in Mississauga may pose serious health risks

   Unauthorized product - Product safety

   Health CanadaOfficial notice →
10. 2026-03-24
11. CA
    Drugs & medicalType II

    Olympus HF Cable

    Performance

    Health CanadaOfficial notice →